-
Your concerns
Our articles to help you gain a better understanding
-
Our solutions
-
DUCRAY Dermatological Laboratories
Resistance of the hair. Preserves your hair’s assets.
Protects hair capital
Helps to preserve the hair’s assets when suffering from chronic hair loss.
• ANACAPS PROGRESSIV Food supplement helps to preserve the hair’s assets
• It is recommended for helping to preserve the hair’s assets when suffering from chronic hair loss due to hormonal, vascular or hereditary causes
• Its formula is composed of IRON, ZINC, SELENIUM and MOLYBDENE as well as a complex of six VITAMINS B, C and E :
- BIOTIN (vitamin B8), ZINC, SELENIUM help to keep the hair healthy
- VITAMIN B6 helps to successfully synthesise cysteine and maintain normal hormonal activity
• SELENIUM, ZINC and VITAMINS C, B2 and E help protect skin cells from oxidative stress
• This nutritional supplement helps to provide the hair with density, volume and resistance*
• One capsule per day to be consumed as a recommended course of treatment for three months
ANACAPS PROGRESSIV Food supplement improves hair density and resistance in over 90%* of patients.
• HELPS TO PRESERVE the hair’s assets : BIOTIN (Vitamin B8), ZINC, SELENIUM help to keep the hair healthy
• CONTAINS 100% of the reference nutritional values for IRON
*% satisfied obtained from 39 female subjects after 3 months of use.
*% satisfied among 39 female subjects after three months of use.
• Take one capsule in the morning with a large glass of water
• Recommended 3-month treatment
• Taking this nutritional supplement should not replace a varied, balanced diet and a healthy lifestyle
• For adults only
• Do not use if pregnant or breastfeeding
• Keep out of the reach of children
• Do not exceed the daily dose indicated
• Use ideally by the date indicated on the packaging
Active ingredient that helps maintain good hair health
Active ingredient that contributes to the normal metabolism of amino acids
Results after 3 months :
• 92%¹ density
• 95%¹ resistance
• 87%¹ volume
¹% satisfied obtained from 39 female subjects after 3 months of use